Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IAT-GIANT: Adjunctive GM1 to Mechanical Thrombectomy for Acute Ischemic Stroke
NCT07519044Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- May 2026
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of monosialotetrahexosylganglioside in ischemic stroke, sponsored by Xuanwu Hospital. Started May 2026; status: recruiting.
02
Drugs
monosialotetrahexosylganglioside
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07519044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519044.